Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study by Agarwal, Neeraj, Prof, McQuarrie, Kelly, BSN, Bjartell, Anders, Prof, Chowdhury, Simon, MD, Pereira de Santana Gomes, Andrea J, MD, Chung, Byung Ha, Prof, Özgüroğlu, Mustafa, Prof, Juárez Soto, Álvaro, MD, Merseburger, Axel S, MD, Uemura, Hirotsugu, Prof, Ye, Dingwei, Prof, Given, Robert, Prof, Cella, David, Prof, Basch, Ethan, Prof, Miladinovic, Branko, PhD, Dearden, Lindsay, MSc, Deprince, Kris, MD, Naini, Vahid, PharmD, Lopez-Gitlitz, Angela, MD, Chi, Kim N, Prof

Get full text

Can Aquaporin-1 and Adipophilin in Urine Distinguish Between Malignant and Nonmalignant Renal Lesions? by Kramer, Mario W., MD, Merseburger, Axel S., MD, Tezval, Hossein, MD

Get full text

Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study by Merseburger, Axel S, Prof, Attard, Gerhardt, MD, Åström, Lennart, MD, Matveev, Vsevolod B, MD, Bracarda, Sergio, MD, Esen, Adil, MD, Feyerabend, Susan, MD, Senkus, Elżbieta, MD, López-Brea Piqueras, Marta, MD, Boysen, Gunther, PhD, Gourgioti, Georgia, MSc, Martins, Karla, MBBCh, Chowdhury, Simon, MD

Get full text

Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, random... by Chi, Kim N, Prof, Higano, Celestia S, MD, Blumenstein, Brent, PhD, Ferrero, Jean-Marc, Prof, Reeves, James, MD, Feyerabend, Susan, MD, Gravis, Gwenaelle, MD, Merseburger, Axel S, Prof, Stenzl, Arnulf, Prof, Bergman, Andries M, MD, Mukherjee, Som D, MD, Zalewski, Pawel, MD, Saad, Fred, Prof, Jacobs, Cindy, MD, Gleave, Martin, Prof, de Bono, Johann S, Prof

Get full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial by Powles, Thomas, MD, Csőszi, Tibor, MD, Özgüroğlu, Mustafa, MD, Matsubara, Nobuaki, MD, Géczi, Lajos, MD, Cheng, Susanna Y-S, MD, Fradet, Yves, Prof, Oudard, Stephane, Prof, Vulsteke, Christof, MD, Morales Barrera, Rafael, MD, Fléchon, Aude, MD, Gunduz, Seyda, MD, Loriot, Yohann, MD, Rodriguez-Vida, Alejo, MD, Mamtani, Ronac, MD, Yu, Evan Y, MD, Nam, Kijoeng, PhD, Imai, Kentaro, MD, Homet Moreno, Blanca, MD, Alva, Ajjai, MD

Get full text

Letter from the Editor-in-Chief by Merseburger, Axel S

Get full text

Transient increased tumescence of the glans penis during penile erection after endovenous ablation of the great saphenous vein by Cordes, Jens, PhD, Zimbelmann, Michael, Merseburger, Axel S., PhD, Kramer, Mario, PhD, Vonthein, Reinhard, PhD, Büttner, Hartwig, PhD, Recke, Andreas, MD, Kahle, Birgit K., PhD

Get full text